PharMerica ( PMC +3.7% ) moves up after beating Q1 estimates late yesterday. Total revenue actually declined 6.8% Y/Y, but margins were
0.5% ) withdraws its hostile offer for nursing-home pharmacy company PharMerica ( PMC -2.6% ) a month after federal regulators raised antitrust issues . PMC says it is " pleased " with the decision, believing that the offer undervalued
welcome to the Fourth Quarter and Year End 2011 PharMerica Corporation Earnings Conference Call. My name is Carissa ..... fourth quarter and year end conference call for PharMerica Corporation . On the call with me today are Greg Weishar
PharMerica ( PMC ): Q4 EPS of $0.27 beats by $0.06 . Revenue of $495.6M (+0.8% Y/Y) misses by $10M . Shares +3.1% AH. ( PR ) Post your comment!
proposed $716M offer for fellow pharmacy provider PharMerica ( PMC ), with a decision expected by the end of next week ..... not trying to look for ways to OK the transaction. PharMerica shares are -11.1% . Post your comment!
Pharmacy services companies Omnicare ( OCR -12% ), and PharMerica ( PMC -15.2% ) crashed today on news of a government proposal to limit the quantity of drugs prescribed to elderly Medicare/Medicaid
We are no longer providing equity research on PharMerica PMC . We provide broad coverage of more than 1,700 companies across more than 140 industries and adjust our coverage as necessary based on client demand and investor interest.
PharMerica ( PMC +2.7% ) follows up its harsh letter to Omnicare ( OCR -2.1% ) with the adoption of a stockholder rights plan designed to thwart an unwelcome takeover. Post your comment!
Pharmerica ( PMC +1.4% ) sends a letter to Omnicare ( OCR -2.2% ) to "set the ..... company: It "undervalues the company and is not in the best interest of PharMerica or its stockholders." Antitrust clearance to combine the two top
all outstanding shares of smaller rival PharMerica ( PMC ) for $441M, or $15.00/share ..... from Monday's close. In a letter to PMC 's board, Omnicare CEO John Figueroa ..... offer directly to shareholders if needed. PMC +37.1% , OCR +8.8% premarket